Pfizer Ltd. — AGM Information 2019

Aug 10, 2019

Pfizer Limited

The Capital, 1802 I 1901, Plot No. C - 70, G Block, Bandra Kurio Complex, Bandra (East), Mumbai 400 051 . Tel: +91 22 6693 2000 Fax: +91 22 2654 0274

August 10, 2019

The Corporate Relationship Dept. BSE Limited 151 Floor, P.J.Towers Dalal Street, Fort Mumbai- 400 001 Scrip Code: 500680

The Manager, Listing Dept. The National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Proceedings of the 681 hAnnual General M eeting- Pfizer Limited

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed proceedings of the 681 h Annual General Meeting of the Company held on August 9, 2019.

We request you to kindly take the same on record.

Thanking you,

Yours truly,

ForJi:::~it ----

Pra~ i=erNa •r Company Secretary

Encl: A/a

CIN : L24231 MH 1950PLC008311

[8] contactus.india@pfizer.com

~; www.pfizerindia.com

Pfizer Limited

The Capital, 1802 I 1901 , Plot No. C- 70, G Block, Bandra Kurio Complex, Bandra (East), Mumbai LtOO 051 . Tel: +91 22 6693 2000 Fax: +91 22 265Lt 027Lt

Fair Summary of Proceedings of the 68th Annual General Meeting of Pfizer limited held on Friday, August 9, 2019 at 3.00 p.m. at Yashwantrao Chavan Pratishthan Auditorium, General Jagannath Bhosale Marg, Next to Sachivalaya Gymkhana, Mumbai - 400 021.

• 1. The 681 h Annual General Meeting of the Members of Pfizer Limited was held on Friday, August 9, 2019 at 3.00 p.m. at Yashwantrao Chavan Pratishthan Auditorium, General Jagannath Bhosale Marg, Next to Sachivalaya Gymkhana, Mumbai- 400 021.
• 2. The meeting was attended by all Directors, Company Secretary, Chief Financial Officer, representative of Auditor, Secretarial Auditor.
• 3. Mr. R. A. Shah took the Chair. The Company Secretary confirmed that the requisite quorum was present and the Chairman commenced the proceedings of the Meeting.
• 4. The Chairman then introduced all the members present on the dais and informed about proxies I representations received and registers available for inspection.
• 5. Mr. R. A. Shah then delivered t he Chairman's Speech to the Shareholders.
• 6. Mr. S. Sridhar, Managing Director made a presentation to the Members giving an overview of the Pharmaceutical Industry, Indian Economy and the Company's performance in 2018-19.
• 7. With the consent of the Members present, the Notice convening the 68th Annual General Meeting, having been circulated to all the Members, was taken as read.
• 8. Since there was no qualification in the Independent Auditors' Report, the same was not required to be read and with the permission of the Members, the Independent Auditors' Report was taken as read .
• 9. The Chairman then took up the Agenda according to the Notice. He informed the Members that he and the Managing Director would be responding to the questions of the Members.
• 10. The Chairman stated that under the Companies Act, 2013, remote e-voting on the proposed resolutions contained in the notice of the Annual General Meeting was mandatory and the same had been provided by the Company. Mr. Bhumitra Dholakia, Designated Partner of Dholakia & Associates LLP, had been appointed Scrutinizer for conducting the remote e-voting and poll ing process in a fair and transparent manner.

11. The Chairman then put the following items on agenda for approval by poll.

Ordinary Business:

• I. To receive, consider and adopt the Audited Financial Statement of the Company for the financial year ended March 31, 2019, together with the Reports of the Board of Directors and Auditors thereon.- Ordinary Resolution
• II. To declare a dividend of Rs. 22.50 (225%} per equity share for the financial year ended March 31, 2019.- Ordinary Resolution
• Ill. To appoint a Director in place of Mr. Vivek Dhariwal (DIN: 02826679L who retires by rotation and being eligible, offers himself for re-appointment.- Ordinary Resolution

Special Business:

• IV. To consider and appoint Mr. Milind Patil (DIN: 02546815} as a Director of the Company, liable to retire by rotation.- Ordinary Resolution
• V. To consider and appoint Mr. Milind Patil (DIN: 02546815} as a Whole-time Director of the Company for a period of 5 years effective November 14, 2018.- Ordinary Resolution
• VI. To consider and appoint Ms. Meena Ganesh (DIN: 00528252} as an Independent Director for a period of 5 years effective March 8, 2019.- Ordinary Resolution
• VII. To consider and re-appoint Mr. R. A. Shah (DIN: 00009851) as an Independent Director of the Company for a period of 5 years effective November 10, 2019. - Special Resolution (Mr. S. Sridhar took the chair for this agenda item as Mr. R. A. Shah was interested in the said agenda item)
• VIII. To consider and re-appoint Mr. Pradip Shah (DIN: 00066242} as an Independent Director of the Company for a period of 5 years effective November 10, 2019.- Special Resolution
• IX. To consider and re-appoint Mr. Uday Khanna (DIN: 00079129) as an Independent Director of the Company for a period of 5 years effective November 10, 2019.- Special Resolution
• X. To consider and re-appoint Mr. Sunil Lalbhai (DIN: 00045590) as an Independent Director of the Company for a period of 5 years effective February 14, 2020.- Special Resolution
• XI. To consider and ratify the remuneration payable to Messrs. RA & Co., Cost Accountants for the financial year ending March 31, 2020.- Ordinary Resolution
• 12. The Shareholders were informed that the results of remote e-voting and poll conducted at the Annual General Meeting would be declared on or before August 11, 2019.
• 13. The Meeting was then concluded with a vote ofthanks to the Chairman.

Thanking you,

Yours truly, For Pfizer limited

p:.t::~~~~------- Company Secretary

Place: Mumbai Date: August 10, 2019